Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 ...

On February 7, 2025, Nevro Corp was acquired by Globus Medical (NYSE ... This performance led to a positive market reaction, with the stock price increasing by 20% following the earnings announcement.

March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical ... changes in fair market value of warrants, stock-based compensation, impairment of goodwill and depreciation and ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition ...